{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:13:02Z","timestamp":1786374782942,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.2459\/jcm.0b013e32833cdcbe","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T08:56:31Z","timestamp":1283331391000},"page":"832-835","source":"Crossref","is-referenced-by-count":1,"title":["Elevation of QT dispersion after obesity drug sibutramine"],"prefix":"10.2459","volume":"11","author":[{"given":"Ahmet A","family":"Yalcin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunyamin","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derun T","family":"Ertugrul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beyza","family":"Algul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamiyet","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur S","family":"Deveci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"Kucukazman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Ata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kursat","family":"Dal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Tutal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210207","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1111\/j.1540-8159.1997.tb06112.x","article-title":"QT interval dispersion and its clinical utility","volume":"20","author":"Kautzner","year":"1997","journal-title":"PACE"},{"key":"R2-8-20210207","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0735-1097(94)00446-W","article-title":"Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study","volume":"25","author":"Zabel","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R3-8-20210207","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2165\/00003495-199856060-00019","article-title":"Sibutramine: a review of its contribution to the management of obesity","volume":"56","author":"McNeely","year":"1998","journal-title":"Drugs"},{"key":"R4-8-20210207","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/sj.ijo.0801931","article-title":"How does sibutramine work?","volume":"25","author":"Lean","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R5-8-20210207","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archinte.164.9.994","article-title":"The efficacy and safety of sibutramine for weight loss: a systematic review","volume":"164","author":"Arterburn","year":"2004","journal-title":"Arch Intern Med"},{"key":"R6-8-20210207","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1381\/096089202321088327","article-title":"Sibutramine warning: hypertension and cardiac arrhythmias reported (editorial)","volume":"2","author":"Deitel","year":"2002","journal-title":"Obes Surg"},{"key":"R7-8-20210207","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2125.2006.02574.x","article-title":"QT interval prolongation associated with sibutramine treatment","volume":"61","author":"Harrison-Woolrych","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"R8-8-20210207","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1542-474X.2006.00093.x","article-title":"QT dispersion increases with aging","volume":"11","author":"Yavuz","year":"2006","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"R9-8-20210207","first-page":"785","article-title":"Mystery of QTc interval dispersion","volume":"79","author":"Marek","year":"1997","journal-title":"Am J Cardiol"},{"key":"R10-8-20210207","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1540-8159.1997.tb06078.x","article-title":"Is dispersion of ventricular repolarisation rate dependent?","volume":"20","author":"Zabel","year":"1997","journal-title":"PACE"},{"key":"R11-8-20210207","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/eurheartj\/ehm217","article-title":"Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial","volume":"28","author":"Torp-Pedersen","year":"2007","journal-title":"Eur Heart J"},{"issue":"Suppl L","key":"R12-8-20210207","first-page":"L44","article-title":"The SCOUT study: risk-benefit profile of sibutramine in overweight high risk cardiovascular patients","volume":"7","author":"Philip","year":"2005","journal-title":"Eur Heart J"},{"key":"R13-8-20210207","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1345\/aph.1L129","article-title":"Sibutramine-associated QT interval prolongation and cardiac arrest","volume":"42","author":"Ernest","year":"2008","journal-title":"Ann Pharmacother"},{"key":"R14-8-20210207","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the Ikr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"R15-8-20210207","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-008-9914-2","article-title":"Effect of sibutramine HCl on cardiac hERG K channel.","volume":"320","author":"Kim","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"R16-8-20210207","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0022-3565(24)37817-6","article-title":"Inhibition of delayed rectifier K channels by dexfenfluramine (Redux)","volume":"287","author":"Hu","year":"1998","journal-title":"J Pharmacol ExpTher"}],"container-title":["Journal of Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01244665-201011000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:17:33Z","timestamp":1786371453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01244665-201011000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2459\/jcm.0b013e32833cdcbe","relation":{},"ISSN":["1558-2027"],"issn-type":[{"value":"1558-2027","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}